Outcome and prognostic factors of CBF pediatric AML patients with t(8;21) differ from patients with inv(16)

Outcome and prognostic factors of CBF pediatric AML patients with t(8;21) differ from patients with inv(16)

Abstract Purpose To explore the outcome and prognostic factors between inv(16) and t(8;21) disrupt core binding factor (CBF) in acute myeloid leukemia (AML). Methods The clinical characteristic, probability of achieving complete remission (CR), overall survival (OS) and cumulative incidence of relap...

Full description

Bibliographic Details
Main Authors: Kun-yin Qiu, Xiong-yu Liao, Yang Li, Ke Huang, Hong-gui Xu, Jian-pei Fang, Dun-hua Zhou
Format: Article
Language:English
Published: BMC 2023-05-01
Series:BMC Cancer
Subjects:
AML
t(8;21)
inv(16)
Outcome
Prognostic factors
Online Access:https://doi.org/10.1186/s12885-023-10965-5

Internet

https://doi.org/10.1186/s12885-023-10965-5

Similar Items